Long-term Immunogenicity of BNT162b2 Vaccine in Patients With Solid Tumors

Ithai Waldhorn, Roy Holland, Tal Goshen-Lago, Madeleine Benguigui, Michael Halberthal, Yuval Shaked, Irit Ben-Aharon

Research output: Contribution to journalLetterpeer-review

Original languageEnglish
Pages (from-to)1-2
Number of pages2
JournalJAMA Oncology
Issue number6
StatePublished - 22 Apr 2022


  • BNT162 Vaccine
  • Humans
  • Neoplasms
  • Vaccines

ASJC Scopus subject areas

  • Oncology
  • Cancer Research

Cite this